Suppr超能文献

相似文献

1
Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications.
Curr Opin Biotechnol. 2013 Dec;24(6):1159-66. doi: 10.1016/j.copbio.2013.02.020. Epub 2013 Apr 9.
2
Theranostic nanomedicine.
Acc Chem Res. 2011 Oct 18;44(10):1029-38. doi: 10.1021/ar200019c. Epub 2011 May 5.
3
Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics.
Theranostics. 2014 Mar 26;4(6):660-77. doi: 10.7150/thno.8698. eCollection 2014.
4
The upcoming field of theranostic nanomedicine: an overview.
J Biomed Nanotechnol. 2012 Dec;8(6):859-82. doi: 10.1166/jbn.2012.1459.
5
Applications of nanoparticles for diagnosis and therapy of cancer.
Br J Radiol. 2015 Oct;88(1054):20150207. doi: 10.1259/bjr.20150207. Epub 2015 Jun 12.
6
Theranostic systems and strategies for monitoring nanomedicine-mediated drug targeting.
Curr Pharm Biotechnol. 2012 Mar;13(4):609-22. doi: 10.2174/138920112799436302.
7
Targeted nanotheranostics for personalized cancer therapy.
Expert Opin Drug Deliv. 2012 Dec;9(12):1475-87. doi: 10.1517/17425247.2012.736486. Epub 2012 Oct 23.
8
Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine.
Adv Mater. 2020 Apr;32(13):e1901989. doi: 10.1002/adma.201901989. Epub 2019 Jul 9.
9
Nanotheranostics: advanced nanomedicine for the integration of diagnosis and therapy.
Nanomedicine (Lond). 2014 Jul;9(9):1277-80. doi: 10.2217/nnm.14.83.
10
Nanotheranostics for personalized medicine.
Adv Drug Deliv Rev. 2012 Oct;64(13):1394-416. doi: 10.1016/j.addr.2012.06.006. Epub 2012 Jun 21.

引用本文的文献

2
Progress in photoreceptor replacement therapy for retinal degenerative diseases.
Cell Insight. 2024 Nov 28;4(1):100223. doi: 10.1016/j.cellin.2024.100223. eCollection 2025 Feb.
4
MRI detection of free-contrast agent nanoparticles.
Magn Reson Med. 2025 Feb;93(2):761-774. doi: 10.1002/mrm.30292. Epub 2024 Sep 29.
5
Extracellular Vesicles: Diagnostic and Therapeutic Applications in Cancer.
Biology (Basel). 2024 Sep 12;13(9):716. doi: 10.3390/biology13090716.
6
A Systematic Study on Long-acting Nanobubbles: Current Advancement and Prospects on Theranostic Properties.
Adv Pharm Bull. 2024 Jul;14(2):278-301. doi: 10.34172/apb.2024.042. Epub 2024 Mar 17.
7
Demystifying the potential of lipid-based nanocarriers in targeting brain malignancies.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Dec;397(12):9243-9279. doi: 10.1007/s00210-024-03212-6. Epub 2024 Jul 4.
8
Biogenic metallic nanoparticles: from green synthesis to clinical translation.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov;397(11):8603-8631. doi: 10.1007/s00210-024-03236-y. Epub 2024 Jun 27.

本文引用的文献

1
Intrinsically active nanobody-modified polymeric micelles for tumor-targeted combination therapy.
Biomaterials. 2013 Jan;34(4):1255-60. doi: 10.1016/j.biomaterials.2012.09.064. Epub 2012 Nov 2.
3
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine.
Adv Drug Deliv Rev. 2012 Oct;64(13):1363-84. doi: 10.1016/j.addr.2012.08.005. Epub 2012 Aug 17.
4
Personalized nanomedicine.
Clin Cancer Res. 2012 Sep 15;18(18):4889-94. doi: 10.1158/1078-0432.CCR-12-1414. Epub 2012 Jul 24.
5
Nanotheranostics for personalized medicine.
Adv Drug Deliv Rev. 2012 Oct;64(13):1394-416. doi: 10.1016/j.addr.2012.06.006. Epub 2012 Jun 21.
7
Ultrasound microbubbles for molecular diagnosis, therapy, and theranostics.
J Nucl Med. 2012 Mar;53(3):345-8. doi: 10.2967/jnumed.111.099754.
8
Drug targeting systems for inflammatory disease: one for all, all for one.
J Control Release. 2012 Jul 20;161(2):225-34. doi: 10.1016/j.jconrel.2011.12.014. Epub 2011 Dec 29.
9
Perspectives and opportunities for nanomedicine in the management of atherosclerosis.
Nat Rev Drug Discov. 2011 Oct 21;10(11):835-52. doi: 10.1038/nrd3578.
10
Theranostic nanomedicine.
Acc Chem Res. 2011 Oct 18;44(10):841. doi: 10.1021/ar200231d.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验